These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


422 related items for PubMed ID: 19924668

  • 1. In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones.
    Chawla B, Agarwal P, Tandon R, Titiyal JS, Sharma N, Agarwal T, Navak N, Satpathy G.
    Eur J Ophthalmol; 2010; 20(2):300-5. PubMed ID: 19924668
    [Abstract] [Full Text] [Related]

  • 2. [In vitro antibiotic susceptibility to fluoroquinolones].
    Wong CA, Galvis V, Tello A, Villareal D, Rey JJ.
    Arch Soc Esp Oftalmol; 2012 Mar; 87(3):72-8. PubMed ID: 22423655
    [Abstract] [Full Text] [Related]

  • 3. In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
    Kowalski RP, Kowalski TA, Shanks RM, Romanowski EG, Karenchak LM, Mah FS.
    Cornea; 2013 Jun; 32(6):830-4. PubMed ID: 23132444
    [Abstract] [Full Text] [Related]

  • 4. Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison.
    Duggirala A, Joseph J, Sharma S, Nutheti R, Garg P, Das T.
    Indian J Ophthalmol; 2007 Jun; 55(1):15-9. PubMed ID: 17189881
    [Abstract] [Full Text] [Related]

  • 5. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
    Alexandrakis G, Alfonso EC, Miller D.
    Ophthalmology; 2000 Aug; 107(8):1497-502. PubMed ID: 10919897
    [Abstract] [Full Text] [Related]

  • 6. Bacterial Keratitis in Toronto: A 16-Year Review of the Microorganisms Isolated and the Resistance Patterns Observed.
    Tam ALC, Côté E, Saldanha M, Lichtinger A, Slomovic AR.
    Cornea; 2017 Dec; 36(12):1528-1534. PubMed ID: 28938380
    [Abstract] [Full Text] [Related]

  • 7. [Antibiotic susceptibility patterns of bacteria isolated from keratitis and intraocular infections at Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia].
    Galvis V, Tello A, Guerra A, Acuña MF, Villarreal D.
    Biomedica; 2014 Apr; 34 Suppl 1():23-33. PubMed ID: 24968033
    [Abstract] [Full Text] [Related]

  • 8. Microbial keratitis in Waikato, New Zealand.
    Pandita A, Murphy C.
    Clin Exp Ophthalmol; 2011 Jul; 39(5):393-7. PubMed ID: 21176039
    [Abstract] [Full Text] [Related]

  • 9. Shifting trends in bacterial keratitis in Toronto: an 11-year review.
    Lichtinger A, Yeung SN, Kim P, Amiran MD, Iovieno A, Elbaz U, Ku JY, Wolff R, Rootman DS, Slomovic AR.
    Ophthalmology; 2012 Sep; 119(9):1785-90. PubMed ID: 22627118
    [Abstract] [Full Text] [Related]

  • 10. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens.
    Callegan MC, Ramirez R, Kane ST, Cochran DC, Jensen H.
    Adv Ther; 2003 Sep; 20(5):246-52. PubMed ID: 14964344
    [Abstract] [Full Text] [Related]

  • 11. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
    Shah VM, Tandon R, Satpathy G, Nayak N, Chawla B, Agarwal T, Sharma N, Titiyal JS, Vajpayee RB.
    Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
    [Abstract] [Full Text] [Related]

  • 12. Shifting Trends in Bacterial Keratitis in Taiwan: A 10-Year Review in a Tertiary-Care Hospital.
    Hsiao CH, Sun CC, Yeh LK, Ma DH, Chen PY, Lin HC, Tan HY, Chen HC, Chen SY, Huang YC.
    Cornea; 2016 Mar; 35(3):313-7. PubMed ID: 26764878
    [Abstract] [Full Text] [Related]

  • 13. Fluoroquinolones in the treatment of bacterial keratitis.
    Bower KS, Kowalski RP, Gordon YJ.
    Am J Ophthalmol; 1996 Jun; 121(6):712-5. PubMed ID: 8644818
    [Abstract] [Full Text] [Related]

  • 14. Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India.
    Reddy AK, Garg P, Alam MR, Gopinathan U, Sharma S, Krishnaiah S.
    Eye (Lond); 2010 Jan; 24(1):170-4. PubMed ID: 19229279
    [Abstract] [Full Text] [Related]

  • 15. Trends in the Microbiological Spectrum of Nonviral Keratitis at a Single Tertiary Care Ophthalmic Hospital in India: A Review of 30 years.
    Joseph J, Karoliya R, Sheba E, Sharma S, Bagga B, Garg P.
    Cornea; 2023 Jul 01; 42(7):837-846. PubMed ID: 35942533
    [Abstract] [Full Text] [Related]

  • 16. In vitro antibiotic resistance in bacterial keratitis in London.
    Tuft SJ, Matheson M.
    Br J Ophthalmol; 2000 Jul 01; 84(7):687-91. PubMed ID: 10873974
    [Abstract] [Full Text] [Related]

  • 17. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
    Kowalski RP, Dhaliwal DK, Karenchak LM, Romanowski EG, Mah FS, Ritterband DC, Gordon YJ.
    Am J Ophthalmol; 2003 Sep 01; 136(3):500-5. PubMed ID: 12967804
    [Abstract] [Full Text] [Related]

  • 18. Ocular Pathogens and Antibiotic Sensitivity in Bacterial Keratitis Isolates at King Khaled Eye Specialist Hospital, 2011 to 2014.
    Al-Dhaheri HS, Al-Tamimi MD, Khandekar RB, Khan M, Stone DU.
    Cornea; 2016 Jun 01; 35(6):789-94. PubMed ID: 27078003
    [Abstract] [Full Text] [Related]

  • 19. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
    Scoper SV.
    Adv Ther; 2008 Oct 01; 25(10):979-94. PubMed ID: 18836691
    [Abstract] [Full Text] [Related]

  • 20. Spectrum and antibiotic sensitivity of bacterial keratitis: a retrospective analysis of eight years in a Tertiary Referral Hospital in Southwest China.
    Guo RQ, Yang J, Yang YB, Chen YN, Xiao YY, Xiang P, Dong MJ, He MF, Wang YT, Xiao YL, Ke HQ, Liu H.
    Front Cell Infect Microbiol; 2024 Oct 01; 14():1363437. PubMed ID: 38529473
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.